CYTEK BIOSCIENCES, INC. Provision for Other Credit Losses
CYTEK BIOSCIENCES, INC. (CTKB) reported Provision for Other Credit Losses of $447.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForOtherCreditLosses · last filed 2026-05-07
- CYTEK BIOSCIENCES, INC. provision for other credit losses for the quarter ending 2026-03-31 was $447.00K.
- CYTEK BIOSCIENCES, INC. provision for other credit losses for the quarter ending 2024-12-31 was $9.00K, a 95.81% decline year-over-year.
- CYTEK BIOSCIENCES, INC. provision for other credit losses for the quarter ending 2024-09-30 was $1.00K, a 97.56% decline year-over-year.
- CYTEK BIOSCIENCES, INC. provision for other credit losses for the quarter ending 2024-06-30 was -$194.00K, a 1485.71% decline year-over-year.
- CYTEK BIOSCIENCES, INC. provision for other credit losses for fiscal 2025 was $419.00K, a 210.37% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. provision for other credit losses for fiscal 2024 was $135.00K, a 50.00% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. provision for other credit losses for fiscal 2023 was $270.00K, a 164.71% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. provision for other credit losses for fiscal 2022 was $102.00K.
| Period end | Provision for Other Credit Losses 3 month | Provision for Other Credit Losses 6 month | Provision for Other Credit Losses 9 month | Provision for Other Credit Losses 12 month |
|---|---|---|---|---|
| 2026-03-31 | $447.00K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $419.00K 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.00K derived: sum of 2 quarters · filed 2026-02-26 | -$184.00K derived: sum of 3 quarters · filed 2026-02-26 | $135.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$193.00K derived: sum of 2 quarters · filed 2024-11-07 | $126.00K 10-Q · filed 2024-11-07 | $341.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $125.00K 10-Q · filed 2024-08-06 | $340.00K derived: sum of 3 quarters · filed 2025-02-28 | $381.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | $319.00K 10-Q · filed 2024-05-08 | $534.00K derived: sum of 2 quarters · filed 2025-02-28 | $575.00K derived: sum of 3 quarters · filed 2025-02-28 | $589.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $256.00K derived: sum of 2 quarters · filed 2025-02-28 | $270.00K derived: sum of 3 quarters · filed 2025-02-28 | $270.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $55.00K derived: sum of 2 quarters · filed 2023-11-14 | $55.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $14.00K 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $102.00K 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |